Abstract
Heart failure is a clinical syndrome characterised by a reduced ability of the heart to pump blood. Patients with heart failure have a high mortality rate, and physicians need reliable prognostic predictions to make informed decisions about the appropriate application of devices, transplantation, medications, and palliative care. In this study, we demonstrate that combining symbolic regression with the Cox proportional hazards model improves the ability to predict death due to heart failure compared to using the Cox proportional hazards model alone.
We used a newly invented symbolic regression method called the QLat-tice to analyse a data set of medical records for 299 Pakistani patients diagnosed with heart failure. The QLattice identified a minimal set of mathematical transformations of the available covariates, which we then used in a Cox model to predict survival.
An exponential function of age, the inverse of ejection fraction, and the inverse of serum creatinine were identified as the best risk factors for predicting heart failure deaths. A Cox model fitted on these transformed covariates had improved predictive performance compared with a Cox model on the same covariates without mathematical transformations.
Symbolic regression is a way to find transformations of covariates from patients’ medical records which can improve the performance of survival regression models. At the same time, these simple functions are intuitive and easy to apply in clinical settings. The direct interpretability of the simple forms may help researchers gain new insights into the actual causal pathways leading to deaths.
Competing Interest Statement
CW and CC are employees of Abzu, which is the company developing and the QLattice technology. CW is also co-founder of the company and the inventor of the patent-pending QLattice technology.
Funding Statement
No external funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The original study containing the data used in this study was approved by the Institutional Review Board of Government College University (Faisalabad, Pakistan). It states that the Helsinki Declaration were followed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data analysed in this study are included in the original published study by Ahmad et al. It can be directly accessed from: https://doi.org/10.1371/journal.pone.0181001.s001 (CSV) Code to reproduce this study is publicly available under the BSD 3-Clause License at: https://github.com/wilstrup/sr-heartfailure The code needs access to a QLattice to run. Abzu grants access to QLattices for free for research purposes. If you need access, please contact the author or the company.
